Bisphosphonate‐induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate‐related osteonecrosis of the jaw-Reference-Cited by-同舟云学术

Bisphosphonate‐induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate‐related osteonecrosis of the jaw

Published:2020-01-16 Issue:7 Volume:91 Page:947-955
ISSN:0022-3492
Container-title:Journal of Periodontology
language:en
Short-container-title:J Periodontol

Author:

Taniguchi Naomi¹²,Osaki Mitsuhiko¹³,Onuma Kunishige¹,Ishikawa Mizuho¹,Ryoke Kazuo²,Kodani Isamu²,Okada Futoshi¹³

Affiliation:

1. Division of Pathological BiochemistryTottori University Faculty of Medicine Yonago Tottori Japan

2. Division of Oral and Maxillofacial Biopathological SurgeryTottori University Faculty of Medicine Yonago Tottori Japan

3. Chromosomal Engineering Research CenterTottori University Yonago Tottori Japan

Publisher

Wiley

Subject

Periodontics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JPER.19-0385

Reference29 articles.

1. Bisphosphonates: calcium antiresorptive agents;DeRuiter J;Endocrine Module Spring,2002

2. Biochemical and molecular mechanisms of action of bisphosphonates

3. Modeling the benefits of pamidronate in children with osteogenesis imperfecta

4. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

5. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonate- and disumab-related gingival disorders: case analysis from the U.S. Food and Drug Administration Adverse Event Reporting System;Frontiers in Endocrinology;2024-08-22

2. A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials;Pharmaceuticals;2024-07-31

3. Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate;Drug Design, Development and Therapy;2024-07

4. S-Allylmercapto-N-Acetylcysteine (ASSNAC) Attenuates Osteoporosis in Ovariectomized (OVX) Mice;Antioxidants;2024-04-17

5. GDF15 Modulates the Zoledronic-Acid-Induced Hyperinflammatory Mechanoresponse of Periodontal Ligament Fibroblasts;Cells;2024-01-12